Tomalik-Scharte, D; Doroshyenko, O; Kirchheiner, J; Jetter, A; Lazar, A; Klaassen, T; Frank, D; Wyen, C; Fätkenheuer, G; Fuhr, U (2008). No role for the CYP3A5*3 polymorphism in intestinal and hepatic metabolism of midazolam. European Journal of Clinical Pharmacology, 64(10):1033-1035.
Statistics
Citations
Dimensions.ai Metrics
Altmetrics
Downloads
Additional indexing
Item Type: | Journal Article, refereed, further contribution |
---|---|
Communities & Collections: | 04 Faculty of Medicine > University Hospital Zurich > Clinic for Clinical Pharmacology and Toxicology |
Dewey Decimal Classification: | 610 Medicine & health |
Scopus Subject Areas: | Life Sciences > Pharmacology
Health Sciences > Pharmacology (medical) |
Language: | English |
Date: | October 2008 |
Deposited On: | 28 Nov 2008 16:47 |
Last Modified: | 27 Jun 2022 18:47 |
Publisher: | Springer |
ISSN: | 0031-6970 |
Additional Information: | The original publication is available at www.springerlink.com |
OA Status: | Green |
Publisher DOI: | https://doi.org/10.1007/s00228-008-0503-9 |
PubMed ID: | 18587567 |
Users (please log in): Suggest update or correction for this item
For submitters/editors: Edit metadata
Permanent URL: https://doi.org/10.5167/uzh-6211
Download
Article Networks
Authors, Affiliations, Collaborations

University of Cologne, Koln, Germany
University of Cologne, Koln, Germany
Universität Ulm, Ulm, Germany
UniversitatsSpital Zurich, Zurich, Switzerland
University of Cologne, Koln, Germany
University of Cologne, Koln, Germany
University of Cologne, Koln, Germany
Uniklinik Köln, Koln, Germany
Uniklinik Köln, Koln, Germany
University of Cologne, Koln, Germany